Fig. 4From: Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year resultsAmputation-free survival in patients treated with smoking cessation, aspirin, and with or without autologous bone marrow-derived mononuclear cell (ABMMNC) treatment; Kaplan-Meier analysis through 10-year follow up. Amputation includes both major and minor amputationsBack to article page